Today, the Susan and Charles Berghoff Foundation announced the public release of its award-winning documentary film, Sue's ...

Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from ...

Cognition Therapeutics, Inc. announced promising results from the SHIMMER study of zervimesine (CT1812) in patients with mild-to-moderate dementia with Lewy bodies (DLB), to be presented by Dr ...

Catherine Laborde, who presented weather on TF1 in France for nearly 30 years, has died. Laborde passed away on Tuesday, Jan. 28 following a years-long battle with Lewy Body Dementia (LBD), which she ...

CervoMed Inc. announced that it will present topline results from its Phase 2b RewinD-LB study at the 8th International Lewy Body Dementia Conference in Amsterdam on January 31, 2025. The study ...

One of the most common early signs of dementia is short-term memory loss—as is forgetting important dates or events, ...

CervoMed (CRVO) provided an update on its neflamapimod development program in dementia with Lewy bodies, DLB, as part of an oral presentation ...

Among patients with iRBD, altered visuospatial cue-elicited N2 and P3 ERPs predicted phenoconversion to α-synucleinopathies.

A number of blood tests have shown promise in research studies but aren’t routinely used in diagnosing dementia.